Go behind the scenes of LogiPharma USA 2026 with program director Charleen Ring and McKesson's Chris Van Norman in this Pharma Pulse special.
Commentary|Podcasts|July 31, 2024
Addressing the Drug Shortage Crisis
Author(s)Nicholas Saraceno, Senior Editor
Peter Ax provides insight as to industry’s lack of supply, along with how to mitigate these issues.
Advertisement
In this exclusive PC Podcast interview, Peter Ax, founder and CEO of UpScriptHealth, a direct-to-consumer telehealth company, describes:
- Why he believes ongoing and active drug shortages are the highest they’ve been since ASHP began tracking this in 2001
- The current landscape of shortages in general
- How drug shortages directly affect patients
- What is needed to alleviate these issues surrounding the supply chain
The latest episode of The Pharmaceutical Commerce Podcast is available directly on
Advertisement
Related to this article
At LogiPharma USA 2026, Cold Chain Technologies' TJ Rizzo explains how gaps in end-to-end cold chain expertise create risk for advanced therapies.
Octapharma USA's Kerem Tokel explains how tariffs and DSCSA are affecting how stolen pharma loads are resold, and why partner SOPs matter.
At LogiPharma USA 2026, Mark Talens explains where pharma gains the most from shared distribution visibility.
In this week's Pharma Pulse, PhRMA sues to block CMS's GLOBE pricing model, WFS opens a temperature-controlled cargo terminal in Lyon and Bayer commits $2.2 billion to a new Ohio manufacturing site.
Freehand CEO Nitin Jayakrishnan explains why pharma manufacturers are trading long-term plans for operating models built to sense and pivot.
At LogiPharma USA 2026, Swisslog's Garrett Freeman explains how onshoring, geopolitical risk and a shifting product mix are driving supply chain automation.
At LogiPharma USA 2026, quality leaders explained why connected data, risk-based prioritization, and human accountability must come before AI in supply chain compliance.
Advertisement
Advertisement